Inventor · disambiguated record
Yuxia Zhang
Also filed as: ZHANG YUXIA
8 granted patents·3 pending applications·16 citations·filing 2012–2022
82Inventor score
Files withWALTER & ELIZA HALL INST MEDICAL RES4GUANGZHOU WOMEN & CHILDRENS MEDICAL CT3THE WALTER AND ELIZA HALL INST OF MEDICAL RES2CHINA PETROLEUM & CHEM CORP1ZHANG YUXIA1
Top patents by PatentIndex Score
11 records- 0182US10010582B2Soluble mediatorWALTER & ELIZA HALL INST MEDICAL RES·Filed 2016·Granted Jul 3, 2018·3 cites·9 claims
- 0276US9585969B2Soluble mediatorTHE WALTER AND ELIZA HALL INST OF MEDICAL RES·Filed 2012·Granted Mar 7, 2017·3 cites·9 claims
- 0375US10413589B2Soluble mediatorWALTER & ELIZA HALL INST MEDICAL RES·Filed 2018·Granted Sep 17, 2019·1 cites·13 claims
- 0474US11123403B2Soluble mediatorWALTER & ELIZA HALL INST MEDICAL RES·Filed 2019·Granted Sep 21, 2021·0 cites·13 claims
- 0573USD982282SInflatable shark costumeZHANG YUXIA·Filed 2022·Granted Apr 4, 2023·7 cites·1 claims
- 0667US9778269B2Method of treating sepsis by administering a soluble CD52 glycoproteinTHE WALTER AND ELIZA HALL INST OF MEDICAL RES·Filed 2013·Granted Oct 3, 2017·2 cites·11 claims
- 0763US10328124B2Soluble mediatorWALTER & ELIZA HALL INST MEDICAL RES·Filed 2018·Granted Jun 25, 2019·0 cites·11 claims
- 0852US12496573B2Catalyst and catalytic oxidation-deoxidation method for unsaturated hydrocarbon-containing gasCHINA PETROLEUM & CHEM CORP·Filed 2021·Granted Dec 16, 2025·0 cites·20 claims
- 0951US2024067683A1Use of mcm8-cgas-sting-ifn-i signal pathway as disease targetGUANGZHOU WOMEN & CHILDRENS MEDICAL CT·Filed 2021·Application pending·0 cites
- 1046US2022260566A1Immunity mechanism and therapeutic drug for gastrointestinal diseasesGUANGZHOU WOMEN & CHILDRENS MEDICAL CT·Filed 2019·Application pending·0 cites
- 1145US2023111925A1Fibrotic disease mechanism and therapeutic drug thereforGUANGZHOU WOMEN & CHILDRENS MEDICAL CT·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuxia Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →